155 related articles for article (PubMed ID: 33249826)
1. Designed Spider Silk-Based Drug Carrier for Redox- or pH-Triggered Drug Release.
Herold HM; Döbl A; Wohlrab S; Humenik M; Scheibel T
Biomacromolecules; 2020 Dec; 21(12):4904-4912. PubMed ID: 33249826
[TBL] [Abstract][Full Text] [Related]
2. Cellular uptake of drug loaded spider silk particles.
Schierling MB; Doblhofer E; Scheibel T
Biomater Sci; 2016 Sep; 4(10):1515-1523. PubMed ID: 27709129
[TBL] [Abstract][Full Text] [Related]
3. Recombinant spider silk particles as drug delivery vehicles.
Lammel A; Schwab M; Hofer M; Winter G; Scheibel T
Biomaterials; 2011 Mar; 32(8):2233-40. PubMed ID: 21186052
[TBL] [Abstract][Full Text] [Related]
4. Water-based preparation of spider silk films as drug delivery matrices.
Agostini E; Winter G; Engert J
J Control Release; 2015 Sep; 213():134-141. PubMed ID: 26100366
[TBL] [Abstract][Full Text] [Related]
5. Engineering of recombinant spider silk proteins allows defined uptake and release of substances.
Doblhofer E; Scheibel T
J Pharm Sci; 2015 Mar; 104(3):988-94. PubMed ID: 25546241
[TBL] [Abstract][Full Text] [Related]
6. Recombinant spider silk particles for controlled delivery of protein drugs.
Hofer M; Winter G; Myschik J
Biomaterials; 2012 Feb; 33(5):1554-62. PubMed ID: 22079006
[TBL] [Abstract][Full Text] [Related]
7. Engineered hybrid spider silk particles as delivery system for peptide vaccines.
Lucke M; Mottas I; Herbst T; Hotz C; Römer L; Schierling M; Herold HM; Slotta U; Spinetti T; Scheibel T; Winter G; Bourquin C; Engert J
Biomaterials; 2018 Jul; 172():105-115. PubMed ID: 29723755
[TBL] [Abstract][Full Text] [Related]
8. Functionalized spider silk spheres as drug carriers for targeted cancer therapy.
Florczak A; Mackiewicz A; Dams-Kozlowska H
Biomacromolecules; 2014 Aug; 15(8):2971-81. PubMed ID: 24963985
[TBL] [Abstract][Full Text] [Related]
9. Recombinant spider silk proteins for applications in biomaterials.
Spiess K; Lammel A; Scheibel T
Macromol Biosci; 2010 Sep; 10(9):998-1007. PubMed ID: 20602494
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Spider Silk Hydrogels for Sustained Release of Biologicals.
Kumari S; Bargel H; Anby MU; Lafargue D; Scheibel T
ACS Biomater Sci Eng; 2018 May; 4(5):1750-1759. PubMed ID: 33445332
[TBL] [Abstract][Full Text] [Related]
11. Engineered spider silk protein-based composites for drug delivery.
Hardy JG; Leal-Egaña A; Scheibel TR
Macromol Biosci; 2013 Oct; 13(10):1431-7. PubMed ID: 23881554
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cellular uptake of engineered spider silk particles.
Elsner MB; Herold HM; Müller-Herrmann S; Bargel H; Scheibel T
Biomater Sci; 2015 Mar; 3(3):543-51. PubMed ID: 26222296
[TBL] [Abstract][Full Text] [Related]
13. Nanostructured, Self-Assembled Spider Silk Materials for Biomedical Applications.
Humenik M; Pawar K; Scheibel T
Adv Exp Med Biol; 2019; 1174():187-221. PubMed ID: 31713200
[TBL] [Abstract][Full Text] [Related]
14. Surface Modification of Spider Silk Particles to Direct Biomolecular Corona Formation.
Weiss ACG; Herold HM; Lentz S; Faria M; Besford QA; Ang CS; Caruso F; Scheibel T
ACS Appl Mater Interfaces; 2020 Jun; 12(22):24635-24643. PubMed ID: 32369330
[TBL] [Abstract][Full Text] [Related]
15. [Engineered spider silk: the intelligent biomaterial of the future. Part II].
Kaźmierska K; Florczak A; Piekoś K; Mackiewicz A; Dams-Kozłowska H
Postepy Hig Med Dosw (Online); 2011 Jun; 65():389-96. PubMed ID: 21734323
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic Vascularization of Recombinant eADF4(C16) Spider Silk Matrices in the Arteriovenous Loop Model.
Steiner D; Lang G; Fischer L; Winkler S; Fey T; Greil P; Scheibel T; Horch RE; Arkudas A
Tissue Eng Part A; 2019 Nov; 25(21-22):1504-1513. PubMed ID: 30848159
[TBL] [Abstract][Full Text] [Related]
17. Processing of recombinant spider silk proteins into tailor-made materials for biomaterials applications.
Schacht K; Scheibel T
Curr Opin Biotechnol; 2014 Oct; 29():62-9. PubMed ID: 24657706
[TBL] [Abstract][Full Text] [Related]
18. Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.
Kozlowska AK; Florczak A; Smialek M; Dondajewska E; Mackiewicz A; Kortylewski M; Dams-Kozlowska H
Acta Biomater; 2017 Sep; 59():221-233. PubMed ID: 28694238
[TBL] [Abstract][Full Text] [Related]
19. Invited review current progress and limitations of spider silk for biomedical applications.
Widhe M; Johansson J; Hedhammar M; Rising A
Biopolymers; 2012 Jun; 97(6):468-78. PubMed ID: 21898363
[TBL] [Abstract][Full Text] [Related]
20. Controlled hydrogel formation of a recombinant spider silk protein.
Schacht K; Scheibel T
Biomacromolecules; 2011 Jul; 12(7):2488-95. PubMed ID: 21612299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
